Glucagon like peptide-1 increases gemcitabine cytotoxicity in human pancreatic cancer stem cells (PCSC)

被引：0
|
作者：
Hui, Hongxiang [1 ,2 ,4 ]
Tang, Yongming G. [3 ]
Zhao, Xiaoning [3 ]
Wang, Kevin [1 ]
Pandol, Stephen J. [1 ,2 ,4 ]
Go, Vay Liang W. [1 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Ctr Excellence Pancreat Dis, Los Angeles, CA 90095 USA
[2] Vet Affairs Greater Angeles Healthcare Syst, Dept Med, Los Angeles, CA USA
[3] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA
[4] So Med Univ, Ctr Metab Dis, Guangzhou, Guangdong, Peoples R China
来源：
REGULATORY PEPTIDES | 2010年 / 164卷 / 01期
关键词：
D O I：
10.1016/j.regpep.2010.07.071
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：30 / 31
页数：2
相关论文
共 50 条
  • [1] Glucagon-like Peptide-1 Increases Pancreatic Enzymes as a Consequence of Proliferation of Exocrine Acinar Cells
    Albrechtsen, Nicolai J. Wewer
    Albrechten, Reidar
    Bremholm, Lasse
    Svendsen, Berit
    Poulsen, Steen S.
    Poulsen, Elisa
    Kuhre, Rune E.
    Janus, Charlotte
    Hilsted, Linda
    Deacon, Carolyn
    Hartmann, Bolette
    Holst, Jens Juul
    DIABETES, 2016, 65 : A486 - A486
  • [2] Protective Role of Glucagon-like Peptide-1 Against Glucosamine-induced Cytotoxicity in Pancreatic Beta Cells
    Kim, Yu-Kyung
    Park, Jae-Hyung
    Park, Sung-Hee
    Lim, Bora
    Baek, Won-Ki
    Suh, Sung-Il
    Lim, Jung-Geun
    Ryu, Gyeong Ryul
    Song, Dae-Kyu
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2010, 25 (2-3) : 211 - 220
  • [3] Amyloidogenicity and Aggregate Cytotoxicity of Human Glucagon-Like Peptide-1 (hGLP-1)
    Poon, S.
    Birkett, N. R.
    Fowler, S. B.
    Luisi, B. F.
    Dobson, C. M.
    Zurdo, J.
    PROTEIN AND PEPTIDE LETTERS, 2009, 16 (12): : 1548 - 1556
  • [4] Enhanced glucagon-like peptide-1 secretion in a patient with glucagonoma: Implications for glucagon-like peptide-1 secretion from pancreatic α cells in vivo
    Yabe, Daisuke
    Rokutan, Mariyo
    Miura, Yoshiyuki
    Komoto, Izumi
    Usui, Ryota
    Kuwata, Hitoshi
    Watanabe, Koin
    Hyo, Takanori
    Kurose, Takeshi
    Nagamatsu, Terumi
    Shimizu, Shinobu
    Kawai, Jun
    Imamura, Masayuki
    Seino, Yutaka
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2013, 102 (01) : E1 - E4
  • [5] Activation of glucagon-like peptide-1 receptor signaling does not modify the growth or apoptosis of human pancreatic cancer cells
    Koehler, JA
    Drucker, DJ
    DIABETES, 2006, 55 (05) : 1369 - 1379
  • [6] Glucagon-Like Peptide-1 and Candesartan Additively Improve Glucolipotoxicity in Pancreatic β-Cells
    Ueno, Hiroaki
    Wang, Hong-Wei
    Mizuta, Masanari
    Noma, Kenji
    Saitoh, Yukie
    Nakazato, Masamitsu
    DIABETES, 2011, 60 : A703 - A703
  • [7] Insulin regulates glucagon-like peptide-1 secretion by pancreatic alpha cells
    Pan Liu
    Jia Song
    He Liu
    Fei Yan
    Tianyi He
    Lingshu Wang
    Huying Shen
    Xinguo Hou
    Li Chen
    Endocrine, 2018, 62 : 394 - 403
  • [8] Insulin regulates glucagon-like peptide-1 secretion by pancreatic alpha cells
    Liu, Pan
    Song, Jia
    Liu, He
    Yan, Fei
    He, Tianyi
    Wang, Lingshu
    Shen, Huying
    Hou, Xinguo
    Chen, Li
    ENDOCRINE, 2018, 62 (02) : 394 - 403
  • [9] Glucagon-like peptide-1 and candesartan additively improve glucolipotoxicity in pancreatic β-cells
    Wang, Hong-Wei
    Mizuta, Masanari
    Saitoh, Yukie
    Noma, Kenji
    Ueno, Hiroaki
    Nakazato, Masamitsu
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2011, 60 (08): : 1081 - 1089
  • [10] Glucagon and glucagon-like peptide-1
    Livingston, JN
    Schoen, WR
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 34, 1999, 34 : 189 - 198
12345